Induction of Anti-Proliferative and Apoptotic Effects of Sorafenib Using miR-27a Inhibitor in Hepatocellular Carcinoma Cell Lines

Volume 22, Issue 9, September 2021, Pages 2951-2958

Abdel Hady A. Abdel Wahab; Eman G Ayad; Mohga S Abdulla; Hayat M Sharada; Abeer M Ashmawy

• View Article
• PDF 905.91 K

The Impact of Sorafenib in Combination with Transarterial Chemoembolization on the Outcomes of Intermediate-Stage Hepatocellular Carcinoma

Volume 22, Issue 4, April 2021, Pages 1217-1224

Masaki Kaibori; Hideyuki Matsushima; Morihiko Ishizaki; Hisashi Kosaka; Kousuke Matsui; Shuji Kariya; Kengo Yoshii; Mitsugu Sekimoto

• View Article
• PDF 348.68 K

The Prognosis of Hepatocellular Carcinoma Treated with Sorafenib in Combination with TACE

Volume 21, Issue 6, June 2020, Pages 1797-1804

Yusuke Kimura; Rena Kaneko; Yuichiro Yano; Kentaro Kamada; Takashi Ikehara; Hidenari Nagai; Yuzuru Sato; Yoshinori Igarashi

• View Article
• PDF 453.18 K

The Synergistic Cytotoxic Effect of Laser-Irradiated Gold Nanoparticles and Sorafenib Against the Growth of a Human Hepatocellular Carcinoma Cell Line

Volume 20, Issue 11, November 2019, Pages 3369-3376

Haidy M Ebrahim; Mahmoud N El-Rouby; Mona E Morsy; Mahmoud M Said; Magda K Ezz

• View Article
• PDF 461.5 K

Sorafenib- Taurine Combination Model for Hepatocellular Carcinoma Cells: Immunological Aspects

Volume 20, Issue 10, October 2019, Pages 3007-3013

Ahmed M Afifi; Ahmed M El-Husseiny; Reda H Tabashy; Mohamed A Khalil; Motawa E El-Houseini

• View Article
• PDF 471.34 K

Novel Combination of Mesenchymal Stem Cell-Conditioned Medium with Sorafenib Have Synergistic Antitumor Effect of Hepatocellular Carcinoma Cells

Volume 20, Issue 1, January 2019, Pages 263-267

Iman Seyhoun; Saieh Hajighasemlou; Jafar Ai; Faezeh Hosseinzadeh; Milad Mirmoghtadaei; Seyed Moein Seyhoun; Benyamin Parseh; Shahrokh Abdolahi; Zeinab Ghazvinian; Mahdi Shadnoush; Javad Verdi

• View Article
• PDF 378.57 K

Characterization and Validation of Hepatocellular Carcinoma (HCC) Xenograft tumor as a Suitable Liver Cancer Model for Preclinical Mesenchymal Stem Cell Studies

Volume 19, Issue 6, June 2018, Pages 1627-1631

Saieh Hajighasemlou; Saeedreza Pakzad; Jafar Ai; Samad Muhammadnejad; Milad Mirmoghtadaei; Faezeh Hosseinzadeh; Safoora Gharibzadeh; Amir Kamali; Akbar Ahmadi; Javad Verdi

• View Article
• PDF 450.56 K

Anti-Vascular Endothelial Growth Factor Effects of Sorafenib and Arsenic Trioxide in Acute Myeloid Leukemia Cell Lines

Volume 18, Issue 6, June 2017, Pages 1655-1661

Atousa Haghi; Saeed Mohammadi; Masoumeh Heshmati; Ardeshir Ghavamzadeh; Mohsen Nikbakht

• View Article
• PDF 1.01 M

Efficacy and Safety of Sorafenib for Advanced Non-Small Cell Lung Cancer: a Meta-analysis of Randomized Controlled Trials

Volume 15, Issue 14, December 2014, Pages 5691-5696

• View Article
• PDF 608.88 K

Sorafenib Continuation after First Disease Progression Could Reduce Disease Flares and Provide Survival Benefits in Patients with Hepatocellular Carcinoma: a Pilot Retrospective Study

Volume 15, Issue 7, July 2014, Pages 3151-3156

• View Article
• PDF 1.07 M

Investigation of Antitumor Effects of Sorafenib and Lapatinib Alone and in Combination on MCF-7 Breast Cancer Cells

Volume 15, Issue 7, July 2014, Pages 3185-3189

• View Article
• PDF 593.9 K

Efficiency and Side Effects of Sorafenib Therapy for Advanced Hepatocellular Carcinoma: A Retrospective Study by the Anatolian Society of Medical Oncology

Volume 14, Issue 12, December 2013, Pages 7367-7369

• View Article
• PDF 348.17 K

Risk of Treatment-related Mortality with Sorafenib in Patients with Cancer

Volume 14, Issue 11, November 2013, Pages 6681-6686

• View Article
• PDF 588.24 K

The Blood Neutrophil-to-lymphocyte Ratio Predicts Survival in Patients with Advanced Hepatocellular Carcinoma Receiving Sorafenib

Volume 14, Issue 9, September 2013, Pages 5527-5531

• View Article
• PDF 480.13 K

Meta-analysis of the Efficacy of Sorafenib for HepatocellularCarcinoma

Volume 14, Issue 2, February 2013, Pages 691-694

• View Article
• PDF 470.77 K